Like others I am a stranger who has valued your contributions here. We have two grown children and four beautiful grandchildren. I would be emotionally overwhelmed by the loss of any one of them. Our very best to you and your family at this difficult time. God bless.
Shekels...you have caharacterized the stock price scenario pretty well. Truth is, until real product information and real clinical results become available all we have to go on is what management says and does. It is worth noting that the FDA judges management committment by their actions, not what they promise or plan, but what they actually do. Our big watchout should be that we have an executive staff of doers and not just planners. My judgment to this point is that we do.
Anything expected today?
Actually, not Rumsfeld but Dr. Peter Senge, " The fifth discipline" . Chair in systems dynamics at MIT. In this context it means that there are events that develop (impact of MANF-Lympo) that will completely change our understanding of some illnesses and medicine as practiced. We do not know what those things will be.Why do some people get AD(PD, other) and others not? Owning AMBS is a leap of faith. We understand that, having done our best to mitigate the risks.
Lets be honest, you don't KNOW any more than the rest of us what is going to happen. You insights are based on a financial hokus pokus spread sheet ...this is NOT GE. If the AMBS model is correct then all medical practice will be impacted(diagnostics and therapudic practice). That is what he is saying. We do not know, what we don't know, ROI is irrelevent at this point. You are having an apples and oranges dialog.
Agree with the thrust of comments and your motivation...none the less, it is a tough thing to watch after recent gains.
I love it when self declared prophets make depositions about what will happen next based on past performances. NO ONE has any idea what this technology will do or what the price accordingly will do. Prediction based on past performance in this case is a foolish mission. Nothing personal but such predictions present no context or understanding of AMBS aside from a superficial green eyeshade model.